首页> 美国政府科技报告 >Effects of In vivo Pentoxifylline Treatment on Survival and Ex vivo VascularContractility in a Rat Lipopolysaccharide Shock Model. (Reannouncement with New Availability Information)
【24h】

Effects of In vivo Pentoxifylline Treatment on Survival and Ex vivo VascularContractility in a Rat Lipopolysaccharide Shock Model. (Reannouncement with New Availability Information)

机译:体内己酮可可碱治疗对大鼠脂多糖休克模型存活和体外血管收缩的影响。 (重新公布新的可用性信息)

获取原文

摘要

Depending on the dose and dosing, pentoxifylline (PTX) treatment can improve orworsen survival from lipopolysaccharide (LPS) shock in rats. Intraperitoneal (i.p.) PTX, 20 mg/kg, administered once 15 min after intravenous (i.v.) LPS (17 mg/kg), significantly improved survival in unanesthetized LPS-shocked rats. Multiple 20 mg/kg PTX injections (five total, spaced at 45 min intervals starting 15 min after LPS) significantly worsened survival. A lower dose, 12 mg/kg, given as a single or multiple injections, did not alter survival. We tested the ex vivo contractile response to norepinephrine (NE) of aortic rings isolated 3.75 hr after i.v. injection of PBS or LPS. Both untreated LPS-shocked and multiple 12 mg/kg PTX treated normal rats (i.v. PBS) had significantly diminished maximum contractility. The ex vivo vascular hypocontractility found in untreated LPS-shocked rats was not aggravated nor ameliorated by multiple 12 mg/kg PTX injections. The ex vivo effects on contractility of multiple 20 mg/kg PTX treatment of LPS shock could not be studied because survival times were shorter than 3.5 hr. In using PTX to treat LPS shock, potentially harmful vasodilation must be considered. dose, dosing, methylxanthine, aorta, norepinephrine, halothane, vasodilation.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号